Why The FDA’s ‘Breakthrough’ Nomination For MDMA Matters - Psychedelic Times
MDMA photo via Flickr user Kripos_NCIS You may have heard that the U.S. Food and Drug Administration recently designated MDMA a ‘breakthrough therapy’—but what the heck does that mean? Currently, the Multidisciplinary Association for Psychedelic Studies is studying MDMA for its usefulness in treating extreme post-traumatic stress disorder (PTSD) in conjunction with psychotherapy. They are …
Continue Reading https://psychedelictimes.com
Join the Discussion